Skip to content
PaperFren

Cardiovascular

Does the inflammation marker CRP actually cause disease?

Prins BP, Abbasi A, Wong A, et al. · PLoS medicine · 2016

Open access · cc by · source: Europe PMC

People born with gene variants that raise their C-reactive protein were not at higher risk of almost any of 32 diseases linked to high CRP, suggesting CRP is mostly a marker rather than a cause, with a surprising lower risk of schizophrenia.

How this study connects

Role on claims

Each row is a claim on a concept or method page where this paper supports, challenges, or qualifies the statement. Roles are hand-checked — not a model guess.

Not yet placed on a claim. This paper has study layers, but no concept page yet cites it as support, challenge, or qualifier.

Study at a glance

Design
Mendelian randomisation — Two genetic risk scores for CRP level (4 SNPs in the CRP gene; 18 genome-wide significant CRP SNPs) were applied to published GWAS summary statistics for 32 outcomes using inverse-variance-weighted estimation, with heterogeneity tests and stepwise SNP removal to handle pleiotropy, a Bonferroni threshold, and individual-level replication for schizophrenia.
N
No single N: outcome datasets ranged from 1,566 to 184,305 participants of European ancestry; the individual-level schizophrenia follow-up used 25,629 cases and 30,976 controls.
Population
Participants of European ancestry in large genome-wide association consortia for 32 autoimmune, cardiovascular, metabolic, neurodegenerative and psychiatric traits.
Outcome
Estimated causal effect of genetically raised CRP on risk of each of 32 diseases or traits (e.g., coronary artery disease, type 2 diabetes, Crohn disease, depression, schizophrenia, blood pressure).

Structured fields used in claim comparison tables when every cited study has a complete layer.

Inspect source passages

Does the inflammation marker CRP actually cause disease?

These passages occur verbatim in the stored paper text. They support the points listed below; they do not verify every statement in the explanation.

32 somatic and psychiatric outcomes were studied

In this large-scale cross-consortium MR study of 32 complex outcomes, we found evidence for a potential protective causal relationship between elevated CRP level and schizophrenia in both genetic IVs (i.e., GRS CRP and GRS GWAS ) and confirmed this protective relationship in follow-up analyses using individual-level genotype data from the schizophrenia GWAS.

4 SNPs in the CRP gene and 18 genome-wide significant SNPs made up the two scores

The first GRS consisted of only four SNPs in the CRP gene (GRS CRP ) selected from the largest recent MR study of CRP [], and the second consisted of 18 SNPs that were associated with CRP level at a genome-wide significance level in the largest GWAS for CRP to date (GRS GWAS ) [].
Read passages in the original paper

Key findings

For most outcomes genetically higher CRP showed no causal effect. Several nominal signals (including coronary artery disease, Crohn disease and blood pressure) disappeared once pleiotropic variants such as those in IL6R were removed. The one robust finding went in an unexpected direction: higher genetically predicted CRP was linked to lower schizophrenia risk (odds ratio 0.86 per 10% higher CRP), confirmed in individual-level data (odds ratio 0.96 per standard deviation of the score), whereas bipolar disorder showed a nominal increase (odds ratio 1.21) that did not survive correction.

Methodology

The researchers used Mendelian randomisation, treating inherited gene variants that nudge CRP levels as a natural experiment. They built two genetic scores for CRP, one from 4 variants in the CRP gene and one from 18 variants across the genome, and applied them to published genetic association results for 32 conditions ranging from heart disease and diabetes to depression and Alzheimer disease. They tested for pleiotropy (variants affecting disease through routes other than CRP), used a strict multiple-testing threshold, and re-checked schizophrenia using individual-level genetic data.

Limitations

The genetic scores explain only about 2% and 5% of variation in CRP, so small causal effects could still be missed, and the heterogeneity-based removal of variants is an imperfect fix for pleiotropy. All data came from people of European ancestry, results rest largely on summary statistics, and the schizophrenia effect is small and its mechanism speculative. A null MR result speaks to lifelong, modest genetic differences in CRP, not necessarily to short-term large rises during illness or to drugs that lower CRP.

Related papers in this topic

Same topic cluster — not a recommendation engine.